Correlation Between Zealand Pharma and RTX AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and RTX AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zealand Pharma and RTX AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zealand Pharma AS and RTX AS, you can compare the effects of market volatilities on Zealand Pharma and RTX AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of RTX AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and RTX AS.

Diversification Opportunities for Zealand Pharma and RTX AS

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Zealand and RTX is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and RTX AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RTX AS and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with RTX AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RTX AS has no effect on the direction of Zealand Pharma i.e., Zealand Pharma and RTX AS go up and down completely randomly.

Pair Corralation between Zealand Pharma and RTX AS

Assuming the 90 days trading horizon Zealand Pharma AS is expected to under-perform the RTX AS. In addition to that, Zealand Pharma is 2.18 times more volatile than RTX AS. It trades about -0.06 of its total potential returns per unit of risk. RTX AS is currently generating about 0.15 per unit of volatility. If you would invest  5,680  in RTX AS on December 27, 2024 and sell it today you would earn a total of  1,460  from holding RTX AS or generate 25.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Zealand Pharma AS  vs.  RTX AS

 Performance 
       Timeline  
Zealand Pharma AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
RTX AS 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in RTX AS are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, RTX AS displayed solid returns over the last few months and may actually be approaching a breakup point.

Zealand Pharma and RTX AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zealand Pharma and RTX AS

The main advantage of trading using opposite Zealand Pharma and RTX AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zealand Pharma position performs unexpectedly, RTX AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RTX AS will offset losses from the drop in RTX AS's long position.
The idea behind Zealand Pharma AS and RTX AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency